This is the first of a two part series on the topic of immune-mediated hemolytic anemia (IMHA) in dogs - a disease that significantly impacts their wellbeing and is an important cause of mortality in affected dogs. This program will serve to empower our audience to make informed decisions regarding the care and management of dogs diagnosed with IMHA. In this first segment the discussion includes:
- How to recognize possible IMHA and properly diagnose the disease
- How to differentiate important types of IMHA and how this can affect making the diagnosis and treatment recommendations for affected patients
- Standard therapy for treating IMHA with glucocorticoids
- Transfusion medicine for managing anemic patients
Running time: 1 hr 28 mins (including 15 mins of question / answer)
Approved for 1.5 hrs of CE credit by AAVSB RACE and NY State
You might also like
Hemangiosarcoma - What We Know And How That's Changing The Paradigm Of Treatment And Prevention
11/13/2024
Hemangiosarcoma is a malignant tumor and, historically, associated with a poor long term prognosis....
Read
More
Treating Cancer - It's Not Just Limited To "chemo" Or "radiation"
11/06/2024
There are different approaches to cancer treatment and, for some types of cancer, the therapy may be...
Read
More
The Current Thinking About What Cancer Is And Its Possible Causes
10/23/2024
Cancer is a term that is often shrouded in uncertainty and fear, but gaining a clear understanding o...
Read
More
Protein-Losing Enteropathy - Therapeutic Management And The Crucial Role Of Nutrition
09/17/2024
In this second session (of a two part series) Dr. Jablonski continues the discussion on patient mana...
Read
More
Protein-Losing Enteropathy In Dogs - Making The Diagnosis
09/10/2024
In this first session (of a two part series) Dr. Jablonski creates a comprehensive understanding of...
Read
More
Caring For Chronic Kidney Disease (CKD) In The Dog - Quality Of Life And End Of Life Considerations
07/09/2024
The focus of this session is on maximizing the quality of life of dogs with chronic kidney disease (...
Read
More
